Motley Fool
Why Moderna Stock Is Hitting Another Record High Today
Shares of Moderna (NASDAQ: MRNA) were jumping 4.3% as of 11:10 a.m. EDT on Thursday, hitting another record high for the stock. The bump came after Michael Yee, an analyst at Jefferies, increased his price target on the stock from $170 to $250. Also, Dr. Marco Cavaleri, the European Medicines Agency (EMA) head of biological health threats and vaccines strategy, stated in a press conference that a committee would likely finalize a decision on recommending authorization for Moderna’s COVID-19 vaccine in children by the end of next week.